SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.83-0.7%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: growthvalue who wrote (24450)8/13/1998 2:13:00 PM
From: medsunman  Read Replies (2) of 32384
 
growthvalue: I've been reading this thread for several months, and I was happy to see you recently join the discussion. I find your perspectives very insightful and knowledgeable. My question to you is this: If the market had already included an ONTAK approval in SRGN's price, and it had a market cap of only $11M, the market wasn't according ONTAK much value was it? Or was the lowly market cap based on concerns of SRGN's ability to continue in business? In any event, how much additional value, if any, do you see the market according LGND's shares if and when ONTAK is approved?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext